SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Małgorzata Krawczyk-Kuliś, Sławomira Kyrcz-Krzemień, Clinical aspects of prophylaxis and treatment of CNS disease in lymphoma patients, Acta Haematologica Polonica, 2015, 46, 1, 20

    CrossRef

  2. 2
    Maro Ohanian, Hagop Kantarjian, Daniel Guy, Deborah Thomas, Elias Jabbour, Susan O’Brien, Inotuzumab ozogamicin in B-cell acute lymphoblastic leukemias and non-Hodgkin’s lymphomas, Expert Opinion on Biological Therapy, 2015, 15, 4, 601

    CrossRef

  3. 3
    Craig A. Portell, Anjali S. Advani, Novel targeted therapies in acute lymphoblastic leukemia, Leukemia & Lymphoma, 2014, 55, 4, 737

    CrossRef

  4. 4
    Aby Abraham, Biju George, Rayaz Ahmed, Auro Viswabandya, Vikram Mathews, Kavitha M. Lakshmi, Vivi M. Srivastava, Mammen Chandy, Alok Srivastava, Outcome of treatment with a low cost protocol in adults with T cell acute lymphoblastic leukemia in a tertiary care center in India, Leukemia & Lymphoma, 2014, 55, 4, 947

    CrossRef

  5. 5
    Sameer A Parikh, Mark R Litzow, Philadelphia chromosome-negative acute lymphoblastic leukemia: therapies under development, Future Oncology, 2014, 10, 14, 2201

    CrossRef

  6. 6
    Dan Douer, Will novel agents for ALL finally change the natural history?, Best Practice & Research Clinical Haematology, 2014, 27, 3-4, 247

    CrossRef

  7. 7
    Dan Douer, Adult Acute Lymphoblastic Leukemia: A Cancer with No Standard of Care, Acta Haematologica, 2013, 130, 3, 196

    CrossRef

  8. 8
    Koji Nagafuji, Toshihiro Miyamoto, Tetsuya Eto, Tomohiko Kamimura, Shuichi Taniguchi, Takashi Okamura, Eiichi Ohtsuka, Takashi Yoshida, Masakazu Higuchi, Goichi Yoshimoto, Tomoaki Fujisaki, Yasunobu Abe, Yasushi Takamatsu, Shouhei Yokota, Koichi Akashi, Mine Harada, Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study), Journal of Hematology & Oncology, 2013, 6, 1, 14

    CrossRef

  9. 9
    A. S. Advani, New immune strategies for the treatment of acute lymphoblastic leukemia: antibodies and chimeric antigen receptors, Hematology, 2013, 2013, 1, 131

    CrossRef